These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Comparison of in vitro antimycobacterial activities of ansamycin and rifampicin]. Tsukamura M, Mizuno S, Toyama H, Ichiyama S. Kekkaku; 1986 Oct; 61(10):497-503. PubMed ID: 3100853 [No Abstract] [Full Text] [Related]
3. [Sensitivity of 7 mycobacterial species to new quinolones]. Gevaudan MJ, Mallet MN, Gulian C, Terriou P, Lagier P, de Micco P. Pathol Biol (Paris); 1988 May; 36(5):477-81. PubMed ID: 3136429 [Abstract] [Full Text] [Related]
4. In vitro susceptibility of Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium avium against some quinolones. Casal M, Rodriguez F, Villalba R, Benavente MC, Gonzalez AI. Chemioterapia; 1987 Dec; 6(6):431-3. PubMed ID: 3481302 [Abstract] [Full Text] [Related]
5. Determination of in vitro susceptibility of mycobacteria to ansamycin. Heifets LB, Iseman MD. Am Rev Respir Dis; 1985 Sep; 132(3):710-1. PubMed ID: 3929660 [Abstract] [Full Text] [Related]
6. [In vitro and in vivo activities of norfloxacin, ofloxacin and ciprofloxacin against various mycobacteria]. Saito H, Sato K, Tomioka H, Watanabe T. Kekkaku; 1987 May; 62(5):287-94. PubMed ID: 3114537 [No Abstract] [Full Text] [Related]
13. Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria. Young LS, Berlin OG, Inderlied CB. Am J Med; 1987 Apr 27; 82(4A):23-6. PubMed ID: 3107379 [Abstract] [Full Text] [Related]